Breast cancer (BC) in men is rare and genetic predisposition is likely to play a relevant role in its etiology. Inherited mutations in BRCA1/2 account for about 13% of all cases and additional genes that may contribute to the missing heritability need to be investigated. In our study, a well-characterized series of 523 male BC (MBC) patients from the Italian multicenter study on MBC, enriched for non-BRCA1/2 MBC cases, was screened by a multigene custom panel of 50 cancer-associated genes. The main clinical-pathologic characteristics of MBC in pathogenic variant carriers and non-carriers were also compared. BRCA1/2 pathogenic variants were detected in twenty patients, thus, a total of 503 non-BRCA1/2 MBC patients were examined in our study. Twenty-seven of the non-BRCA1/2 MBC patients were carriers of germline pathogenic variants in other genes, including two APC p.Ile1307Lys variant carriers and one MUTYH biallelic variant carrier. PALB2 was the most frequently altered gene (1.2%) and PALB2 pathogenic variants were significantly associated with high risk of MBC. Non-BRCA1/2 pathogenic variant carriers were more likely to have personal (p = 0.0005) and family (p = 0.007) history of cancer. Results of our study support a central role of PALB2 in MBC susceptibility and show a low impact of CHEK2 on MBC predisposition in the Italian population. Overall, our data indicate that a multigene testing approach may benefit from appropriately selected patients with implications for clinical management and counseling of MBC patients and their family members.

Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy / Rizzolo, Piera; Zelli, Veronica; Silvestri, Valentina; Valentini, Virginia; Zanna, Ines; Bianchi, Simonetta; Masala, Giovanna; Spinelli, Alessandro Mauro; Tibiletti, Maria Grazia; Russo, Antonio; Varesco, Liliana; Giannini, Giuseppe; Capalbo, Carlo; Calistri, Daniele; Cortesi, Laura; Viel, Alessandra; Bonanni, Bernardo; Azzollini, Jacopo; Manoukian, Siranoush; Montagna, Marco; Peterlongo, Paolo; Radice, Paolo; Palli, Domenico; Ottini, Laura. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - 145:2(2019), pp. 390-400. [10.1002/ijc.32106]

Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy

Rizzolo, Piera;Zelli, Veronica;Silvestri, Valentina;Valentini, Virginia;Giannini, Giuseppe;Capalbo, Carlo;Ottini, Laura
2019

Abstract

Breast cancer (BC) in men is rare and genetic predisposition is likely to play a relevant role in its etiology. Inherited mutations in BRCA1/2 account for about 13% of all cases and additional genes that may contribute to the missing heritability need to be investigated. In our study, a well-characterized series of 523 male BC (MBC) patients from the Italian multicenter study on MBC, enriched for non-BRCA1/2 MBC cases, was screened by a multigene custom panel of 50 cancer-associated genes. The main clinical-pathologic characteristics of MBC in pathogenic variant carriers and non-carriers were also compared. BRCA1/2 pathogenic variants were detected in twenty patients, thus, a total of 503 non-BRCA1/2 MBC patients were examined in our study. Twenty-seven of the non-BRCA1/2 MBC patients were carriers of germline pathogenic variants in other genes, including two APC p.Ile1307Lys variant carriers and one MUTYH biallelic variant carrier. PALB2 was the most frequently altered gene (1.2%) and PALB2 pathogenic variants were significantly associated with high risk of MBC. Non-BRCA1/2 pathogenic variant carriers were more likely to have personal (p = 0.0005) and family (p = 0.007) history of cancer. Results of our study support a central role of PALB2 in MBC susceptibility and show a low impact of CHEK2 on MBC predisposition in the Italian population. Overall, our data indicate that a multigene testing approach may benefit from appropriately selected patients with implications for clinical management and counseling of MBC patients and their family members.
2019
BRCA1/2; cancer susceptibility genes; germline mutations; male breast cancer; multigene panel testing
01 Pubblicazione su rivista::01a Articolo in rivista
Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy / Rizzolo, Piera; Zelli, Veronica; Silvestri, Valentina; Valentini, Virginia; Zanna, Ines; Bianchi, Simonetta; Masala, Giovanna; Spinelli, Alessandro Mauro; Tibiletti, Maria Grazia; Russo, Antonio; Varesco, Liliana; Giannini, Giuseppe; Capalbo, Carlo; Calistri, Daniele; Cortesi, Laura; Viel, Alessandra; Bonanni, Bernardo; Azzollini, Jacopo; Manoukian, Siranoush; Montagna, Marco; Peterlongo, Paolo; Radice, Paolo; Palli, Domenico; Ottini, Laura. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - 145:2(2019), pp. 390-400. [10.1002/ijc.32106]
File allegati a questo prodotto
File Dimensione Formato  
Giannini_Genetic-susceptibility.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 1.06 MB
Formato Adobe PDF
1.06 MB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1279470
Citazioni
  • ???jsp.display-item.citation.pmc??? 18
  • Scopus 33
  • ???jsp.display-item.citation.isi??? 32
social impact